IP Library Granted Patent US 7,939,645
Granted Patent B2
US 7,939,645 · App. 11/651,169 · Granted May 10, 2011

Reaction buffer composition for nucleic acid replication with packed DNA polymerases

Assignee: Agilent Technologies, Inc
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,939,645
App. No.
11/651,169
Granted
May 10, 2011
Kind
B2
Abstract

The invention relates to compositions, methods, and kits for nucleic acid replication, including polymerase chain reaction (PCR) and mutagenesis reactions. A buffer composition is provided which allows higher concentrations of DNA polymerase to be used, resulting in greater yield of amplified product and faster reaction kinetics.

Claims (51)

1. A composition for nucleic acid replication, comprising a mineral salt, ammonium sulfate, and at least one fusion DNA polymerase, said composition having a mineral salt:ammonium sulfate molar ratio in the range from about 30:1 to 240:1,

wherein the DNA polymerase(s) concentration is at least 6 units per 50 μl.

2. The composition of claim 1 , wherein the mineral salt:ammonium salt molar ratio is in the range from about 30:1 to 80:1.

3. The composition of claim 1 , wherein the mineral salt concentration is in the range from 50 mM to 120 mM.

4. The composition of claim 3 , wherein the mineral salt concentration is in the range from 80 mM to 100 mM.

5. The composition of claim 1 , wherein the ammonium sulfate concentration is in the range from 1 mM to 5 mM.

6. The composition of claim 1 , wherein the mineral salt concentration is in the range from 50 mM to 120 mM and the ammonium sulfate concentration is in the range from 1 mM to 5 mM.

7. The composition of claim 1 , wherein the composition comprises magnesium sulfate.

8. The composition of claim 7 , wherein the magnesium sulfate concentration is in the range from 1 mM to 3 mM.

9. The composition of claim 8 , wherein the magnesium sulfate concentration is 2 mM.

10. The composition of claim 1 , wherein the composition comprises Tris sulfate buffer.

11. The composition of claim 10 , wherein the Tris sulfate concentration is in the range from 15 mM to 50 mM.

12. The composition of claim 11 , wherein the Tris sulfate concentration is 30 mM.

13. The composition of claim 10 , wherein the pH of the solution is in the range from 8 to 11.

14. The composition of claim 13 , wherein the pH is 10.

15. The composition of claim 13 , wherein the pH is 9.

16. The composition of claim 1 , wherein the mineral salt concentration is in the range from 50 mM to 120 mM, the ammonium sulfate concentration is in the range from 1 mM to 5 mM, and the composition comprises magnesium sulfate at a concentration in the range from 1 mM to 3 mM and Tris sulfate at a concentration in the range from 15 mM to 50 mM.

17. The composition of claim 1 , comprising 50 mM mineral salt, 1 mM ammonium sulfate, 30 mM Tris sulfate adjusted to pH 10.0, 2 mM magnesium sulfate, and 0.1% Triton X-100.

18. The composition of claim 1 , comprising 80 mM mineral salt, 1.5 mM ammonium sulfate, 30 mM Tris sulfate adjusted to pH 10.0, 2 mM magnesium sulfate, and 0.1% Triton X-100.

19. The composition of claim 1 , comprising 100 mM mineral salt, 2 mM ammonium sulfate, 30 mM Tris sulfate adjusted to pH 10.0, 2 mM magnesium sulfate, and 0.1% Triton X-100.

20. The composition of claim 19 , wherein essentially all of the anions are sulfate ions.

21. The composition of claim 1 , further comprising one or more nucleotides.

22. The composition of claim 1 , wherein said DNA polymerase is exo-Pfu-Sso7d or exo-Pfu V93R-Sso7d.

23. The composition of claim 1 , wherein the DNA polymerase concentration is in the range of 50 to 100 units per 50 μl.

24. The composition of claim 1 , wherein the DNA polymerase concentration is at least 10 units per 50 μl.

25. The composition of claim 1 , wherein the DNA polymerase concentration is at least 20 units per 50 μl.

26. The composition of claim 1 , wherein the DNA polymerase concentration is in the range of 6 to 25 units per 50 μl.

27. The composition of claim 1 , further comprising a nucleic acid template.

28. The composition of claim 1 , further comprising a primer.

29. The composition of claim 1 , further comprising a polymerization enhancing factor.

30. The composition of claim 1 , further comprising one or more nucleotides, one or more nucleic acid polymerases, a nucleic acid template, and a primer.

31. A buffer concentrate for preparing a DNA polymerase reaction solution, wherein dilution by a factor ranging from 2 -fold to 20 -fold yields the composition of claim 1 .

32. The buffer concentrate of claim 31 , wherein dilution by a factor ranging from 5-fold to 10-fold yields said composition.

33. A buffer concentrate for preparing a DNA polymerase reaction solution, wherein dilution by 5-fold to 10-fold yields composition of claim 16 .

34. A buffer concentrate for preparing a DNA polymerase reaction solution, wherein dilution by 5-fold to 10-fold yields composition of claim 17 .

35. A buffer concentrate for preparing a DNA polymerase reaction solution, wherein dilution by 5-fold to 10-fold yields composition of claim 18 .

36. The buffer concentrate of claim 31 , further comprising one or more nucleotides.

37. The buffer concentrate of claim 31 , further comprising one or more nucleic acid polymerases.

38. The buffer concentrate of claim 37 , wherein the DNA polymerase is a Pfu-Sso7d or exo-Pfu V93R-Sso7d.

39. The buffer concentrate of claim 37 , wherein the DNA polymerase is Pyrococcus GB-D-furiosus-Sso7d.

40. The buffer concentrate of claim 31 , further comprising a Fen nuclease.

41. The buffer concentrate of claim 31 , further comprising a nucleic acid template.

42. The buffer concentrate of claim 31 , further comprising a primer.

43. The buffer concentrate of claim 31 , further comprising a polymerization enhancing factor.

44. A kit for the replication of a nucleic acid sample, comprising the buffer concentrate of claim 36 and packaging material therefor.

45. The kit of claim 44 further comprising one or more nucleotides, one or more nucleic acid polymerases, a Fen nuclease, one or more primers, a nucleic acid template, or a polymerization enhancing factor.

46. The composition of claim 1 , wherein the mineral salt is selected from the group consisting of potassium sulfate, potassium chloride, potassium nitrate, cesium chloride, and cesium nitrate.

47. The composition of claim 46 , wherein the mineral salt is potassium sulfate.

48. The composition of claim 1 , wherein the mineral salt is a mixture of salts selected from the group consisting of potassium sulfate, potassium chloride, potassium nitrate, cesium chloride, and cesium nitrate.

49. The composition of claim 1 , wherein the concentration of the mineral salt component of said composition is in the range of 50 mM and 120 mM.

50. The composition of claim 1 ; wherein the DNA polymerase is Pfu-Deep Vent-Sso7d.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2026
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 075020/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2011
From: BORNS, MICHAEL
To: STRATAGENE CALIFORNIA
Reel/Frame 025974/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2011
From: BORNS, MICHAEL
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 025974/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2010
From: STRATAGENE CALIFORNIA
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 024630/0870 →
Continuity (2)
Provisional Application 60757120 · Jan 6, 2006
Related Publication 20080038782A1 · Feb 14, 2008